Top-News

Bioage Labs Aktie News

Aktie
WKN:  A40D7P ISIN:  US09077V1008 US-Symbol:  BIOA Branche:  Pharmazeutika Land:  USA
10,20 €
+0,2 €
+2,00%
07:40:01 Uhr
Depot/Watchlist
Marktkapitalisierung *
240,68 Mio. €
Streubesitz
27,79%
KGV
-2,92
Index-Zuordnung
-

Bioage Labs News

14.02.25 - PR Newswire
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA PR Newswire
13.02.25 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit - BIOA
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit - BIOA PR Newswire
12.02.25 - PR Newswire
BIOAGE LABS, INC. (BIOA) INVESTORS WHO LOST MONEY HAVE OPPORTUNITY TO LEAD SECURITIES FRAUD LAWSUIT
BIOAGE LABS, INC. (BIOA) INVESTORS WHO LOST MONEY HAVE OPPORTUNITY TO LEAD SECURITIES FRAUD LAWSUIT PR Newswire
11.02.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
11.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA PR ...
11.02.25 - PR Newswire
Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA PR Newswire
10.02.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
10.02.25 - PR Newswire
The Gross Law Firm Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
The Gross Law Firm Reminds BioAge Labs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA PR Newswire
10.02.25 - PR Newswire
BIOA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
BIOA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class ...
09.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP PR Newswire
07.02.25 - PR Newswire
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA PR Newswire
06.02.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
06.02.25 - PR Newswire
Contact The Gross Law Firm by March 10, 2025 Deadline to Join Class Action Against BioAge Labs, Inc.(BIOA)
Contact The Gross Law Firm by March 10, 2025 Deadline to Join Class Action Against BioAge Labs, Inc.(BIOA) PR Newswire
05.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
04.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA PR ...
04.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
04.02.25 - PR Newswire
BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
03.02.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP PR Newswire
03.02.25 - PR Newswire
Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire
31.01.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire

Newssuche

Videos

newspaper
08.12.25 -4,60%
Technical Trading: Die besten 3 Tage
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Abschluss!
Grande Portage Resources Ltd
0,236 €
+19,8%
Grande Portage Resources Ltd Chart
Sprott zieht durch - und der Markt sollte aufwachen!
Mehr zur Aktie »